Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

AT-527

SKU: orb691966

Description

AT-527, a hemisulfate salt of AT-511, a guanosine nucleotide prodrug, is a potent and orally active HCV viral replication inhibitor. AT-527 is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC90=0.47 μM). AT-527 has pangenoty

Research Area

Product Categories/Products/Small Molecules,Product Categories/Products/Small Molecules/Inhibitors

Images & Validation

Key Properties

CAS Number[2241337-84-6]
MW1261.156
FormulaC48H68F2N14O18P2S
SMILESC[C@]([C@](O[C@@H]1CO[P@](OC2=CC=CC=C2)(N[C@@H](C)C(OC(C)C)=O)=O)([H])N3C4=NC(N)=NC(NC)=C4N=C3)([C@@H]1O)F.OS(O)(=O)=O.[1/2]

Storage & Handling

Expiration Date12 months from date of receipt.
Hazard InformationNon-Toxic
DisclaimerFor research use only

Similar Products

  • anti-mTopaz [orb1463264]

    IEM,  IF,  IHC-Fr,  IHC-P,  WB

    Goat

    Polyclonal

    Unconjugated

    100 μg
  • AT-511(Bemnifosbuvir free base) [orb691965]

    [1998705-64-8]

    581.533689260483

    C24H33FN7O7P

    1 ml x 10 mm (in DMSO), 100 mg, 250 mg, 1 g
  • AT-273 [orb757561]

    299.1

    C11H14FN5O4

    5 mg
  • Ethyl eosin [orb2566295]

    98.00%

    6359-05-3

    714.03

    C22H11Br4KO5

    50 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

1 ml x 10 mm (in DMSO)
$ 390.00
100 mg
$ 1,020.00
250 mg
$ 1,670.00
1 g
$ 3,370.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry